Myopia and Early-Onset Type 2 Diabetes: A Nationwide Cohort Study.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
18 01 2022
Historique:
received: 14 07 2021
pubmed: 11 9 2021
medline: 19 2 2022
entrez: 10 9 2021
Statut: ppublish

Résumé

A correlation between myopia and insulin resistance has been suggested. We investigated the association between myopia in adolescence and type 2 diabetes (T2D) incidence in young adulthood. This population-based, retrospective, cohort study comprised 1 329 705 adolescents (579 543 women, 43.6%) aged 16 to 19 years, who were medically examined before mandatory military service during 1993 to 2012, and whose data were linked to the Israel National Diabetes Registry. Myopia was defined based on right-eye refractive data. Cox proportional models were applied, separately for women and men, to estimate hazard ratios (HRs) for T2D incidence per person-years of follow-up. There was an interaction between myopia and sex with T2D (P < .001). For women, T2D incidence rates (per 100 000 person-years) were 16.6, 19.2, and 25.1 for those without myopia, and with mild-to-moderate and high myopia, respectively. These corresponded to HRs of 1.29 (95% CI, 1.14-1.45) and 1.63 (1.21-2.18) for women with mild-to-moderate and high myopia, respectively, compared to those without myopia, after adjustment for age at study entry, birth year, adolescent body mass index, cognitive performance, socioeconomic status, and immigration status. Results persisted in extensive sensitivity and subgroup analyses. When managed as a continuous variable, every 1-diopter lower spherical equivalent yielded a 6.5% higher adjusted HR for T2D incidence (P = .003). There was no significant association among men. For women, myopia in adolescence was associated with a significantly increased risk for incident T2D in young adulthood, in a severity-dependent manner. This finding may support the role of insulin resistance in myopia pathogenesis.

Identifiants

pubmed: 34505129
pii: 6368107
doi: 10.1210/clinem/dgab669
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e663-e671

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Alon Peled (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Assaf-Harofeh Medical Center, Zerifin, Israel.

Itamar Raz (I)

The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.

Inbar Zucker (I)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ministry of Health, Israel Center for Disease Control, Ramat Gan, Israel.

Estela Derazne (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Jacob Megreli (J)

Hebrew University-Hadassah Braun School of Public Health and Community, Jerusalem, Israel.
Israel Defense Forces Medical Corps, Ramat Gan, Israel.

Orit Pinhas-Hamiel (O)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.

Adi Einan-Lifshitz (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Assaf-Harofeh Medical Center, Zerifin, Israel.

Yair Morad (Y)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Assaf-Harofeh Medical Center, Zerifin, Israel.

Eran Pras (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Assaf-Harofeh Medical Center, Zerifin, Israel.

Miri Lutski (M)

Ministry of Health, Israel Center for Disease Control, Ramat Gan, Israel.

Tali Cukierman-Yaffe (T)

Ministry of Health, Israel Center for Disease Control, Ramat Gan, Israel.
Institute of Endocrinology, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.

Ofri Mosenzon (O)

The Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.

Dorit Tzur (D)

Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Amir Tirosh (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Institute of Endocrinology, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.

Hertzel C Gerstein (HC)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Arnon Afek (A)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Central Management, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.

Gilad Twig (G)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Israel Defense Forces Medical Corps, Ramat Gan, Israel.
Institute of Endocrinology, Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.
Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH